Cargando…
FKBPL: a marker of good prognosis in breast cancer
FK506-binding protein-like (FKBPL) has established roles as an anti-tumor protein, with a therapeutic peptide based on this protein, ALM201, shortly entering phase I/II clinical trials. Here, we evaluated FKBPL's prognostic ability in primary breast cancer tissue, represented on tissue microarr...
Autores principales: | Nelson, Laura, McKeen, Hayley D., Marshall, Andrea, Mulrane, Laoighse, Starczynski, Jane, Storr, Sarah J., Lanigan, Fiona, Byrne, Christopher, Arthur, Ken, Hegarty, Shauna, Ali, Ahlam Abdunnabi, Furlong, Fiona, McCarthy, Helen O., Ellis, Ian O., Green, Andrew R., Rakha, Emad, Young, Leonie, Kunkler, Ian, Thomas, Jeremy, Jack, Wilma, Cameron, David, Jirström, Karin, Yakkundi, Anita, McClements, Lana, Martin, Stewart G., Gallagher, William M., Dunn, Janet, Bartlett, John, O’Connor, Darran, Robson, Tracy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494933/ https://www.ncbi.nlm.nih.gov/pubmed/25906750 |
Ejemplares similares
-
FKBPL: a novel prognostic and predictive biomarker?
por: McKeen, HD, et al.
Publicado: (2010) -
The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway
por: Yakkundi, Anita, et al.
Publicado: (2013) -
Role of the Hsp90 cochaperone, FKBPL, in oestrogen receptor signalling and breast cancer growth and survival
por: McKeen, H, et al.
Publicado: (2008) -
FKBPL Is a Critical Antiangiogenic Regulator of Developmental and Pathological Angiogenesis
por: Yakkundi, Anita, et al.
Publicado: (2015) -
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer
por: Annett, Stephanie, et al.
Publicado: (2019)